ghp lobal health & pharma Q3 2024 www.ghp-news.com Transforming patient administration with empathy, efficiency and innovation.
Welcome to the Q3 2024 edition of Global Health & Pharma magazine, providing you with all the latest news and features across the healthcare and pharmaceutical landscape. Q3 2024 Gracing this issue’s front cover is UPIC Health, which we have named as Best Patient Administration Partner 2024 – USA. Led by Founder and CEO Mary Tucker, UPIC Health lifts the burden of administration for healthcare providers and hospitals by allowing them to outsource and streamline those tedious tasks, freeing their clinicians up so they can focus on what really matters: delivering the very best service to their patients. Read on to discover how UPIC Health is making the lives of both its clients and their patients easier through its exceptional service and solution offering. Elsewhere in this issue, we are delighted to be showcasing more of our award-winning organisations who operate in industries such as life science and microbiology research, skincare products, hair growth products, facial aesthetics, gut health supplements, healthcare content marketing, peak performance coaching and hypnotherapy, and many more. Delve into each organisation’s story of innovation and resilience as they each contribute towards the health and wellbeing of our societies. We hope you find this issue to be informative and inspiring, and we look forward to welcoming you back again soon for our Q4 issue. Rebecca Scotland, Editor Website: www.ghp-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.
Contents 4. News 7. UPIC Health LLC: Transforming patient administration with empathy, efficiency and innovation. 8. Herspiegel: Best Life Science Commercialization Consultancy Firm 2024 – USA 9. ergoflix Group GmbH: A New Take on Mobility Solutions 10. Health Carousel: Healthcare CTO of the Year 2024 (USA): Zack Storer 12. Advena Ltd: Ensuring Compliance for Medical Devices and In- Vitro Medical Devices 14. Environmental Horizons Co: Most Innovative Environmental Services Provider 2024 - Saudi Arabia 16. Ink Illusions: Restoring Confidence Through Transformative Tattoo Treatments 17. Soapstones Natural Skincare Inc: Feel Good. Do Good. 18. The Clinic: Enhance Your Natural Beauty 19. Corza Medical: Leading Innovation in Wound Closure Products 20. Englegård: Holistic Norwegian Skincare Solutions 21. Pantheon Apothecary: From Routine to Ritual 22. PrecisionBiotics®: Probiotic Precision 23. Pure + Simple: The Pure and Simple Skincare Difference 24. IndySoft Europe Ltd: Exemplary Calibration Management Solutions 25. Naturcosmo GmbH: Most Pioneering Algae- Based Products Experts 2024 26. Huna Skin Inc: Organic and Sustainable Herbal Skin Health 27. Jland Biotech: The Land of Collagen Evolution 28. Rapid Mind Redesign: Best Peak Performance Coach and Hypnotherapist 2024 (Middle East): Samira Alexander 30. Dermalase Laser & IPL Training Services: The Father-Daughter Duo Shaping an Industry 31. Neogen Europe Ltd: Most Innovative Life Science & Microbiology Research Company 2024 - UK 32. EG Aesthetics Ltd: Quality Essex-Based Aesthetics 33. Timeless Lines Aesthetics: Timeless Aesthetics, Timeless Beauty 34. Dr Raquel Skin and Medical Cosmetics: Helping You Nurture Your Natural Beauty 35. Aha Media Group: Dedicated Healthcare Marketing 36. Boley Nutraceuticals Ltd: Transform Your Body from the Inside Out 37. Linical: Taking the Legwork out of Your Clinical Trials 38. micosmeticusk: The Best in Class for Essex Aesthetics 39. Watermans: Homegrown and High-Quality Hair Growth Solutions 40. AquaClinical: Innovating Health, One Trial at a Time 41. BDK Ltd: Earlier Detection, Quicker Recovery, Better Health 42. Suncombe Limited: The Undisputed Market Leader in Decontamination Solutions 43. Sebastian Rose Medical Aesthetics: Where Affordability and Excellence Unite 44. Trident Medical Ltd: Put Your Event in Safe Hands 45. Lupin Healthcare: A Steadily Rising Pillar of Generic Medicine Supply 46. OncoGenomX: Oncology’s Groundbreaking AI Solution
NEWS • Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis and Research • Agreement Plans to Facilitate a Technology Transfer of C2N’s Proprietary Portfolio of Alzheimer’s Blood Biomarkers to Deliver a Unilabs Testing Network Across Europe ST. LOUIS, MO. and GENEVA, SWITZERLAND Unilabs (“Unilabs”), a leading international provider of diagnostic services, and C2N Diagnostics, LLC (“C2N”), a pioneer in advanced diagnostic solutions in the field of Alzheimer’s disease (AD) and related neurological disorders, today announced a major milestone in brain health diagnostics and research across Europe and beyond. Unilabs and C2N have signed a multi-year partnership agreement that will increase access to C2N’s Precivity portfolio of blood tests on an exclusive basis in Europe, including Norway, Switzerland, and the United Kingdom. The agreement will also C2N Diagnostics and Unilabs announce global partnership, bringing together innovation leaders in diagnostics and laboratory medicine to advance brain health provide access in Peru, Saudi Arabia, and the United Arab Emirates. “Alzheimer’s disease is on the rise, making it essential to innovate by offering less invasive and more accessible diagnostic procedures for patients,” said Unilabs’ Head of Innovation Dr. Rahul Chaudhary. “All too often, diagnosing Alzheimer’s has been painful, invasive and expensive. This partnership will transform the diagnostic experience for patients with cognitive concerns while revolutionizing early diagnosis, and research efforts, and positively impacting long-term outcomes.” He continues, “C2N’s Precivity portfolio of blood tests and its innovative biomarker pipeline offer the highest performance precision tools in the industry1. We expect these innovations to appeal to healthcare providers in Europe, the Gulf Region and Latin America who rely on us, and to our biopharma collaborators who are developing new therapies. Patients worldwide deserve access to an early diagnosis, leveraging personalized medicine tools that can enable better treatment decisions and activate long-term disease prevention strategies. We are confident these tests can help in achieving better outcomes for patients, as we continue in our mission to power health and maximize life.” C2N’s Precivity portfolio of blood tests aid healthcare providers and researchers in the detection of amyloid plaques and neurofibrillary “tau” tangles in the brain, which are pathological hallmarks of Alzheimer’s disease. These tests also help to inform medical management and treatment decisions based on the underlying causes of dementia. This strategic partnership also plans to facilitate a technology transfer of C2N’s proprietary portfolio of Alzheimer’s blood biomarkers to deliver a Unilabs testing network across Europe, ensuring Precivity testing can be performed at qualified healthcare institutions with the same quality, consistency and accuracy currently delivered at C2N’s central CAP/CLIA lab in St. Louis, Mo.
Tuesday 3 September 2024 – AMLo Biosciences Ltd (Newcastle upon Tyne, UK) announce the successful receipt of the UKCA mark for AMBLor. AMBLor is a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis. This is the first in vitro diagnostic (IVD) of its kind that can reliably stratify non-ulcerated AJCC stage I-II melanomas that are unlikely to metastasise, potentially segmenting a group of patients that could be spared further diagnostic procedures and lengthy follow-up schedules. The UKCA label allows AMBLor to be marketed in Great Britain, meaning the test is now available to healthcare professionals. A recent Freedom of Information Act (FOI) request from the Liberal Democrats shows a 25% increase in patients on NHS waiting lists for skin cancer treatment and around 3,500 patients wait longer than the 62-day standard to start treatment, with some left waiting almost a year1. Nationwide use of AMBLor could help reduce waiting lists by identifying people whose melanomas are low risk and needing fewer appointments, thereby enabling more time slots to be available for other patients. Using the patients’ original skin biopsy, AMBLor identifies the presence of two prognostic proteins, AMBRA1 and loricrin, in the skin overlying the tumour. Absence of both these biomarkers in melanoma is associated with tumours at risk of metastasis or spread. The presence of one or both biomarkers is associated with a low risk of progression. Recently published validation data for AMBLor demonstrated a negative predictive value of 96.5%2, demonstrating the high accuracy with which the test can identify low-risk tumours. Around 20% of early stage I or II melanomas progress to metastatic disease, and the majority of deaths from melanoma occur in this early-stage group. With no accurate predictor of low-risk melanoma recurrence, all patients have had to follow the same disease management guidance3. This can involve sentinel lymph node biopsy, other imaging tests and up to 5-years of follow-up. Sentinel lymph node biopsy has a significant complication rate and recent meta-analysis has shown it to be less accurate in older people4,5. Patients can experience high levels of anxiety that can affect many aspects of daily life. Dr Marie Labus, CEO, AMLo Biosciences, commented, “We are excited that AMBLor has now received its UKCA mark and is available to the NHS and private hospitals. Adding this simple, effective, low-cost biomarker assay to the existing early-stage melanoma diagnostic tests can provide accurate prognostic information relating to tumour progression. We believe that it can enable clinicians to provide a more personalised approach to disease management, which may include consideration of the need for sentinel lymph node biopsy, also potentially easing patient anxiety at a difficult time.” Melanoma experts reported that having better prognostic information for earlystage melanoma could help reduce the burden of procedures and appointments on both patients and the stretched healthcare resources, plus it could assist in offering tailored treatment options and follow-up6. Mr Aidan Rose, FRCS (Plast), Consultant Plastic Surgeon, Newcastle upon Tyne Hospitals NHS Foundation Trust, added, “AMBLor receiving a UKCA mark is really great news. Now that it is available for use, we are very hopeful that it can be used to aid clinical decision making and help reduce the significant strains that many services are currently experiencing.” AMLo Biosciences offer an AMBLor e-learning package for pathologists. Please contact the company for access – details below. To order the AMBLor kit in the UK or request training details please contact: [email protected] or telephone 0191 580 7180. For general information: www.amlo-biosciences.com AMBLor® prognostic melanoma biomarker successfully receives UKCA mark Both companies believe this partnership will transform global Alzheimer’s disease diagnosis for patients with cognitive concerns or at high risk of future AD or ADrelated dementias. Healthcare Sector Eager for Easy-to-Access, Less Invasive Tests C2N previously announced in 2020 that the PrecivityAD® blood test achieved the CE Mark from the European Union (EU) and also has In Vitro Diagnostic Regulation legacy device status under Regulation (EU) 2017/746, which allows for commercial availability in the EU as an in vitro diagnostic to aid in the evaluation of patients with mild cognitive impairment or dementia. In addition, the United Kingdom’s Medicines and Healthcare Products Regulatory Agency approved the PrecivityAD blood test as an in-vitro diagnostic to aid in the diagnosis of Alzheimer’s disease. C2N CEO, Dr. Joel Braunstein says, “The sobering impact of Alzheimer’s disease reaches beyond any one country’s borders and that’s why it’s vital we respond to the global interest in our Precivity blood tests. We believe this collaboration allows for the acceleration of equitable access to the highest quality blood biomarkers that can aid in the diagnosis of Alzheimer’s disease. To date, we’ve secured other international arrangements and now, we’re very proud to enter this multifaceted strategic affiliation with Unilabs, an organization that places a premium on quality in testing and in personalized diagnostics for Alzheimer’s disease.” The PrecivityAD2™ and PrecivityAD blood tests use highly sensitive and specialized laboratory technologies to identify and measure certain proteins that are found in the blood and that are known to be associated with the presence of brain amyloid plaques, one of the brain pathology findings of Alzheimer’s disease. The main test result is a clinically validated score that determines a patient’s likelihood category for the presence of brain amyloid plaques. Like other tests that evaluate for brain amyloid pathology in clinical patients, such as amyloid PET scan or cerebrospinal fluid (CSF) testing, the Precivity blood tests can be used by healthcare providers to interpret the test results, along with other medical information. The tests are intended for use in patients 55 years and older with signs or symptoms of mild cognitive impairment or dementia. These tests are only available for order by qualified healthcare providers. C2N and Unilabs expect the Precivity portfolio of blood tests will become available to Unilabs customers over the coming months, depending on geographic region. To inquire further about timelines for a specific country please email [email protected] or [email protected].
NEWS
7 GHP Q3 2024 Celebrating a Decade of Transforming Healthcare: UPIC Health’s Impact on Patient Care and Administrative Efficiency As healthcare evolves, one truth remains: the need for efficient, empathetic, and seamless administrative systems is more critical than ever. For the past 10 years, UPIC Health LLC has been at the forefront of healthcare outsourcing, revolutionizing how health networks manage their administrative and revenue cycle functions. By centralizing these crucial processes, UPIC Health has created a ripple effect that improves patient outcomes, reduces costs, and accelerates reimbursements. A Visionary Approach to Healthcare Outsourcing UPIC Health began with a deep understanding of the healthcare industry’s looming challenges—rapid administrative changes, complex patient needs, and the pressure to deliver more with less. From the start, UPIC was driven by a simple yet powerful mission: to be the backbone of patient and provider interactions, offering a “one-stop shop” for care coordination, access, and revenue cycle management. Through this approach, the company has handled millions of patient calls over the past decade, managing everything from routine inquiries to emotionally charged, complex financial conversations. During the COVID-19 pandemic, UPIC rose to the occasion, meeting a 40% surge in patient volume while ensuring the safety and wellbeing of its employees—a testament to its employee-centric ethos. Empathy at the Core At UPIC Health, the mantra is clear: “Happy, safe, and supported employees lead to happy, safe, and supported patients.” This core belief is woven into the fabric of the company’s culture, and it’s reflected in everything they do. With an average employee tenure of 8.5 years, UPIC’s commitment to continuous training, equitable salaries, and flexible work-from-home options has cultivated a highly skilled and motivated team that consistently delivers exceptional service. “Being awesome, helping others, and creating positive experiences for everyone involved is the UPIC way,” explains the company’s founder. This guiding principle has allowed UPIC to not only reduce the administrative burdens on healthcare providers but also to optimize the patient experience by minimizing stress and creating a reliable support system for patients and providers alike. Introducing Med Ops Lab: Order Out of Chaos One of UPIC’s latest innovations, Med Ops Lab, is a game-changer for health networks looking to streamline their operations. Designed to address inefficiencies and align processes across disparate systems, Med Ops Lab provides a specialized team that embeds within a healthcare network for six months. This team meticulously cleans up outdated workflows, documents standard operating procedures, and creates optimized patient journey maps—all while identifying opportunities for continuous improvement. “Our clients often face a significant disconnect between strategy and execution,” says UPIC’s founder. “Many come to us with fragmented processes, siloed communications, and unoptimized technology. Med Ops Lab bridges that gap, turning chaos into calm and preparing organizations for a seamless transition to either outsourcing with UPIC or enhancing their internal teams.” With a transparent cost structure based on a cost-plusmanagement fee, Med Ops Lab offers tailored solutions to each healthcare network’s unique needs. Whether a system requires two specialists or six, UPIC ensures that all inefficiencies are identified, documented, and resolved, laying the groundwork for long-term success. A Legacy of Excellence and Innovation UPIC Health’s influence reaches far beyond the administrative realm. By uniting compassion with operational expertise, the company has set a new standard for healthcare outsourcing. Its reputation has been built not through flashy marketing, but through word-of-mouth referrals from satisfied clients who trust UPIC to handle their most critical patient and revenue cycle needs. As UPIC Health celebrates its 10th anniversary, it looks to the future with the same dedication to excellence that has defined its past. With the launch of Med Ops Lab and continued innovations in patient communication and revenue cycle management, UPIC remains committed to improving healthcare for patients and providers alike. Global Health & Pharma is proud to recognize UPIC Health as the Best Patient Administration Partner 2024 – USA, a title that reflects the company’s unwavering commitment to transforming healthcare through empathy, expertise, and exceptional service. Transforming patient administration with empathy, efficiency and innovation.
8 GHP Q3 2024 Founded in 2007, Herspiegel has evolved from offering launch planning and management to world-class commercializationservices.Thisevolution is driven by a clear understanding of its clients’ needs, leading it to develop an integrated approach that spans the entire lifecycle of a product. In light of Herspiegel being named our Best Life Science Commercialization Consultancy Firm 2024 – USA, we take a closer look at what makes it so worthy of this title. A Comprehensive Suite of Services Today, Herspiegel stands out in the industry with its comprehensive suite of services, which includes medical communications, analytics and insights, launch and marketing excellence, market access, and patient services design. Its unique ability to combine these diverse functions into a cohesive strategy ensures that clients can navigate the complexities of the life sciences market with confidence and precision. Herspiegel’s cross-functional expertise allows it to deliver deep insights and tailored strategies that are essential for brand and portfolio success. The firm prides itself on its ability to simplify complexity, providing actionable insights and incisive strategies across all functional areas. This holistic approach not only optimizes brand success but also enhances the patient experience and demonstrates value to stakeholders. Proven Track Record of Success With a track record of helping to launch over 135 products in the last 15 years, Herspiegel has played a significant role in building enduring brands for some of the world’s largest pharmaceutical companies. Its reputation as a trusted partner is built on its ability to align commercial strategy with operational excellence, ensuring clients achieve their business objectives. Cross-Functional Excellence What sets Herspiegel apart is its exceptional team of experienced leaders who bring a wealth of knowledge across various therapeutic areas. Clients benefit from executive-level engagement and a unified team approach that leverages Herspiegel’s cross-functional acumen. This integrated model not only streamlines processes but also minimizes the need for multiple vendors, providing a seamless experience for clients. Client-Centric Approach Despite its growth and success, Herspiegel remains committed to a client-centric ethos. As a midsized boutique firm, it provides personalized attention and acts as a true partner to its clients. Its dedication to maintaining strong client relationships and delivering exceptional results is at the core of everything it does. Looking Ahead As Herspiegel celebrates the remarkable achievement of being named Best Life Science Commercialization Consultancy Firm 2024 – USA, it looks forward to continuing its journey of innovation and excellence. We are honored to recognize Herspiegel’s contributions to the life sciences industry and are excited about its future as it continues to help clients achieve commercial success. For more information about Herspiegel’s services and how it can help your business, please visit the company website at www. herspiegel.com. Company: Herspiegel Email: [email protected] Website: www.herspiegel.com Best Life Science Commercialization Consultancy Firm 2024 – USA Brent Herspiegel, CEO & Founder, Beth Schurman, COO & Cofounding Partner
9 GHP Q3 2024 ith an increased standard of living and an ageing population present right across Europe, there is clearly a need for devices that help combat the indicators of an older population. In a market littered with cheap products seeking to take advantage, one name shines for its quality solutions. Disrupting industry norms, ergoflix was founded in 2017 and brought the first foldable electric wheelchairs with subsidy from the health insurance company to the German mobility aid sector. In just a few short years, the company has undergone considerable growth as a result of its pioneering approach. Today, aside from being a leader in the German medical device market, it also profits from subsidiaries in both Austria and France. Germany alone sees an active sales network of more than 600 partners, meaning that ergoflix sells thousands of wheelchairs across Europe every year. Quite simply, it does this by always focusing on the customer, solving their needs and developing the products that are right for them. As a result, the message that ergoflix sends to its customers is a positive one, this being that life is beautiful, regardless of what a person’s situation may look like. With the mobility products, users can travel independently again and expand their radius. Passionate about social impact and inclusion, the company’s portfolio covers all life situations and is characterised by the highest quality – this is also reflected in low complaint rate. The brand’s bestseller is the all-round ergoflix® LX, a design which comes in a number of stylish colour combinations such as red and black or black and white. Boasting its status as the ultimate travel companion, the ergoflix® LX effortlessly strikes the balance between being lightweight and reliable. Aside from its range of 24 km and puncture-proof solid rubber wheels, the chair also possesses such features as an ergonomic backrest, the ability to adjust the firmness of the seat, as well as terrific suspension that makes indoor and outdoor travel a breeze. For added peace of mind, this chair also comes with a three-year warranty, underpinning its dependability. The lightweight and foldable nature of all of these electric wheelchairs is a further distinguishing point, a game changer for those who prize their independence and seek to travel, unencumbered by a mobility aid that is heavy and takes up lots of space. ergoflix also has a number of specially developed accessories in its range, such as ramps for loading the chair into a vehicle, and adapters that allow the joysticks to be swivelled away and thus enable them to be driven under a table. ergoflix Group GmbH is committed to reducing the stigma surrounding medical aids through its pioneering smart and aesthetic electric wheelchairs. Recognised as the Best Foldable Electric Wheelchair Design Company 2024 – Europe for its efforts, the team here are tackling loneliness whilst increasing the independence and quality of life of people with physical limitations. This is achieved through a line of innovative mobility products that are not only highly functional, but also visually appealing, moving away from the pretence that mobility aids are a sign of weakness. A New Take on Mobility Solutions The past six years have seen the brand grow immensely, and some of its highlights include being recognised as a growth champion by leading German business newspaper FOCUS, as well as placing in the top 50 of The Financial Times’ growth ranking of 1000 businesses. Awards and accolades have followed, with these successes enabling the team to launch a number of social impact projects. One such project, with football club Fortuna Düsseldorf, ergoflix is setting an example for accessibility and social participation. As part of this project, one lifelong fan of the club, 60-year-old Roger, was gifted a free visit to a home match as well as the ergoflix® LX foldable electric wheelchair. After facing difficulties walking and getting about in the years prior, Roger was finally provided an opportunity to visit his beloved stadium for a game, an incredibly powerful moment for him, the club, and ergoflix alike. Looking ahead, the company is soon to release another item in its line of innovative mobility products, this time a wheelchair accessory called the Universal Holder, upgrading the armrest of a chair with capabilities to hold the likes of a mobile phone, large or small clip-on bags , or even a side mirror. With the Universal Holder, ergoflix now offer the opportunity to travel even more flexibly and comfortably. Using the sort of groundbreaking technology FIDLOCK found in the bicycle industry, this product has seen the company partner with leading wheelchair bag supplier Quokka for the best results. The accessories are designed by the in-house research & development department and are unique on the market. A pioneer in foldable electric wheelchairs across the continent, ergoflix Group GmbH is more than deserving of being named as the Best Foldable Electric Wheelchair Design Company 2024 – Europe. Company: ergoflix Group GmbH Web Address: https://ergoflix.de/ Email: [email protected] W Jun24015
10 The drive to improve communities, families, and individual lives is at the heart of Zack Storer’s lifetime of endeavors. This passion was even further cemented in 2021 when acute myopericarditis nearly took his life, and he was supported by skilled ER and nursing staff, ultimately making a full recovery. Deeply appreciative of the thousands of actual lives saved when burnout and healthcare worker turnover was highest during the second wave of the pandemic, Zack resolved to further give back to an industry that will see unprecedented demand over the next decade as the US population ages. In an era where technological advancements are as crucial as medical breakthroughs, Zack Storer has immersed in the broader industry and worked to achieve for the common good. Recently named Healthcare CTO of the Year (USA), his journey from the tech trenches to the pinnacle of ecosystem innovations is a testament to the power of visionary leadership bringing scaled engineering into the heart of a business. His adaptability and innovative mindset have made him a beacon of progress across technology sectors and have multiplied the impact through his early-stage investment firm, Angel Equity. “Zack possesses a unique blend of deep technical understanding, strategic business thinking and strong leadership skills. His energy and love for people make him a solid change agent and operator. Zack makes big ideas happen.”-Chad Jackson, Director of Healthcare Strategy and Product, The Kroger Co. | 85.41 Zack’s leadership has not only generated billions of dollars in value but also improved millions of lives worldwide. His lifetime of working to improve societal health spans diverse verticals including: launching early digital Health & Wellness solutions, eCommerce/ Fulfillment, and Mobile capabilities at the Kroger Co. (NYSE:KR), striving to make food healthier through computer vision systems/ IoT and the elimination of harmful products used in traditional food production through Controlled Environment Agriculture (CEA), investments in personal and mental health startups through Angel Equity, and now helping grow the healthcare worker population through international nursing and education at Health Carousel. “Zack entered Health Carousel at a time of great change for the industry and the organization. His expertise in technology, paired with high business acumen, helped evolve what was a traditional IT organization into an embedded digital group that is core to business strategy, product creation, and solution delivery for clients and customers. Zack is a driver, a creative thought partner, and a systems builder; one of the most noteworthy: a culture of empowerment. While we’ve crossed paths over the years, it’s been a pleasure to get the chance to work closely, learning and building together.” -Tony Blankemeyer, Head of Product Planning & Analytics, Health Carousel Under his leadership, Health Carousel has undergone a revolutionary overhaul of its technological strategies to significantly advance omni-channel nursing platforms and scale. While Storer’s career spans leading in high-stakes arenas, from multibillion-dollar public retail giants to advising and investing in high growth companies, he is currently investing his time directly in the healthcare industry. His recent accomplishments have distinguished him as a Healthcare CTO of the Year and recent CIO of the Year Orbie finalist. The healthcare landscape, still grappling with the effects of a global pandemic, faces numerous challenges. An aging population, increasing complexity of healthcare needs, and a shortage of skilled professionals are just the beginning. At the helm of Health Carousel’s technological innovation, Storer has been pivotal in deploying cutting-edge solutions to get healthcare workers when and where they are needed most and partnering to improve access to healthcare services across the United States. Health Carousel has fully embraced digital transformation with the launch of ‘On Demand’, a platform that uniquely enables a native end-to-end digital journey for healthcare workers filling critical roles across the industry. These platforms streamline the process of staffing and managing healthcare professionals, ensuring that the right skills are available at the right time, thereby significantly enhancing service delivery and patient care. Storer’s influence extends beyond strategic foresight; his operational tactics deliver lasting value and foster an infectious culture of innovation. His approach, focusing on scalable, sustainable innovative solutions, has driven growth and positioned companies he is passionate about to be market leaders. The results speak for themselves: dramatic increases in growth, improved health and wellness, and mentoring industry talent that further fuel cutting-edge advances across planet. “Zack’s vision for enabling users with a new experience, above and beyond just the technical change, allowed the value of the new platform to be understood and supported at the executive level of the organization. His ability to communicate this vision was a key driver to the success of transformation.” -John West, Sr. Architect, Microsoft Beyond the boardroom, advisory, and digital transformation, Storer’s impact is profoundly personal. His dedication to improving Healthcare CTO of the Year 2024 (USA): Zack Storer Improving the World’s Health Through Curiosity and Pioneering Technology
GHP Q3 2024 the health and lives of people across all areas and walks of life is palpable. He brings a unique blend of technical acumen and empathetic leadership to the table, endeavoring to resonate deeply with his teams and the communities they serve. “Zack truly embodies the modern leader. He listens more than he speaks, he supports his team doesn’t try to bend them and he uses his unusually wide and deep industry experience to digitally transform aging companies. On a personal note, Zack is my mentor and has helped me selflessly grow my career in a sustainable way.”- Ateesh Vankayala, AI Product Strategy Leader, Stealth One of the standout aspects of Zack’s journey is his relentless pursuit of learning and adaptation. His academic pursuits at institutions like Stanford, Cornell, UC, and MIT, coupled with his rich hands-on experience across multiple industries, have equipped him with the rare ability to navigate and lead through complex challenges across every sector. This adaptability and drive to learn are crucial in an industry as dynamic and impactful as healthcare especially with the rise of democratized AI. As a visionary leader in technology and digital transformation, Zack stands out prominently in an ever-evolving AI data and math-driven healthcare landscape with a relentless focus on growth and impact. “Zack came to lead the technology team at Bowery at a critical time during the pandemic. Very quickly, he helped build stronger relationships across the team, address key recurring resource gaps, and position us well for the future. I truly appreciate the charisma he brought to the team and the impact he made in helping the team unify to progress towards a better future, and a better planet.”-Caleb Reed, Staff Data Scientist, Duolingo To get in touch with Zack Storer regarding keynote requests, board advisory, or philanthropic partnerships, inquiries can be made through LinkedIn or www.relentlesscuriosity.com. Contact Details Awardee’s Company: Health Carousel Media Contact: Brian LeCount Website: www.healthcarousel.com / www.relentlesscuriosity.com
12 GHP Q3 2024 o market medical devices and in-vitro medical devices, manufacturers must ensure a compliant product, and Advena is an authority in this arena. Comprising a seasoned team of experts in quality management and regulatory knowledge, the company is the ideal partner for any manufacturer requiring advice and representation within the EU market. It’s more than earnt the accolade of Best Medical Device Regulatory Consultancy Firm 2024 – Europe. As an EU authorised representative, Advena may be appointed by manufacturers outside the EU who wish to sell and place medical devices and in-vitro medical devices on the EU market. The company acts as each client’s point of contact within the EU, able to navigate regulatory concerns on their behalf. As a founding member of the European Association of Authorised Representatives (EAAR), it’s not just enhancing clients’ operations; it’s playing a part to better the industry. Moreover, Advena prides itself on going beyond the fundamental obligations, also providing guidance, professional advice, and vital regulatory news. The team believes that simply acting as a point of contact doesn’t add sufficient value, and that helping clients to understand the latest developments is key in empowering them to make informed decisions. Through its association with the EAAR, May24294 T As EU regulations change, so too does the burden of compliance for medical and in-vitro medical devices. Ensuring that products meet regulatory standards is an increasingly complex challenge, and it’s often a costly one for companies to tackle in-house. The answer to this problem is leading regulatory consultancy Advena Limited. it’s always apprised of the latest knowledge and ready to pass it along to keep businesses running smoothly. Recent rising standards for compliance have put strain on companies producing medical equipment, and this places a heavy burden on those which don’t have the luxury of being able to delegate this increased responsibility. This includes changes to EU legislation, including new directives and regulations for both medical devices and in-vitro medical devices. Manufacturers now find it more difficult and expensive to meet regulatory demands, though Advena is always ready to step in and lower the impact of these changes. “Advena can ease the drain on your internal resources by providing cost-effective solutions. We have a very broad level of experience, offer great service, and keep our fees competitive.” Advena’s exceptional service is backed by outstanding KPIs. at 91.1% for response time, 93% for advice given, and 94.6% concerning fees, the company stands at a 93% on overall performance. It’s a prime example of a medical device consultancy which takes service seriously, and clients laud its EU REP services as swift and supportive. “We have been with Advena Ltd since 1998 and view them as a real friend to smaller companies trying to navigate the ever-changing regulatory landscape. John Adcock and his team have always been there for us with quick and solid answers to our most challenging questions. We have only ever had positive experiences along the way working with them.” “Although the journey to CE marking has been somewhat tricky, the help and assistance given from Advena has been excellent, and I’ll happily be quoted on that.” “We shifted over from an alternate authorised rep a few years ago, and the service provided by Advena far exceeds that provided by the previous authorised rep. The staff are easy to reach and work with you on whatever needs to be done.” For all medical device and in-vitro medical device consultancy needs, as well as ISO 13485 QMS consultancy, Advena is making its mark among the most informed and trusted companies around. The team alleviates EU compliance concerns at a competitive price, and it’s always up to date with the latest news to help clients stay ahead of the curve. Contact: Anthony Kirby Company: Advena Ltd Web Address: www.advena.mt Ensuring Compliance for Medical Devices and In-Vitro Medical Devices
13 GHP Q3 2024 a a a Who We Are Skin Elements is a formulation company. Centred on Research and Development, Skin Elements has an advanced process for creating and commercialising innovative natural formula’s. Awarded Australian biotech Skin Elements heads to the UK
14 Since its inception in 2007, Environmental Horizons (EH) has emerged as a trailblazer in the environmental services sector of Saudi Arabia. Under visionary leadership, EH has become synonymous with toptier environmental solutions, earning a reputation for excellence and innovation. Our commitment to sustainability and environmental stewardship is at the heart of our operations, significantly contributing to the Kingdom’s Vision 2030. Through its comprehensive range of services, it addresses complex environmental challenges, ensuring that its solutions are both effective and forward-thinking. Most Innovative Environmental Services Provider 2024 - Saudi Arabia Environmental Horizons: Leading the Charge in Sustainable Solutions A Legacy of Excellence Founded with the vision to address pressing environmental challenges, Environmental Horizons has established itself as a premier environmental and sustainability services provider. Its extensive portfolio includes environmental studies and consultancy, industrial and hazardous waste management, insulation and lining services for landfill cells, environmental emergency response, and the rehabilitation of contaminated sites. Over the years, its expertise has enabled it to serve a diverse array of clients, from governmental institutions to industrial giants, ensuring that it remains at the forefront of environmental innovation and compliance. Its strategic approach combines rigorous scientific analysis with practical, scalable solutions, enabling it to deliver impactful results that drive positive environmental change. Our Vision Contributing to the implementation and success of national environmental policies and initiatives, and to the improvement of the quality of life in the Kingdom, while supporting a viable and sustainable industrial development approach. Contributing to the development of the environmental services sector in the Kingdom and transforming it to a regional and international reference in terms of regulations, practices, and export of innovative green solutions. Commitment to Sustainability and Compliance EH takes pride in its adherence to the highest standards of environmental compliance, supported by a dedicated international workforce of engineers, scientists, and researchers from various nationalities. Its operations are licensed and approved by the National Center for Environmental Compliance (NCEC), the National Center for Waste Management (MWAN), and the Royal Commission for Jubail & Yanbu. This rigorous approval process underscores its dedication to operating within the strictest environmental regulations, ensuring that its services not only meet but exceed industry standards. The company’s commitment to sustainability is reflected in its approach to environmental studies and consultancy. It works closely with its clients to develop tailored solutions that address their unique environmental challenges while promoting sustainable practices. Its expertise in waste management, particularly industrial hazardous waste, is crucial in helping industries navigate complex regulations and implement effective waste reduction strategies.
GHP Q3 2024 expand its services beyond KSA. It is excited about the opportunities to further its impact and continue its mission of providing exceptional environmental services. Its dedication to innovation, compliance, and client satisfaction positions it as a leader in the environmental sector, ready to tackle the challenges of tomorrow. Its forward-looking strategy includes investing in emerging technologies, expanding its service offerings, and building strategic alliances that enhance its ability to deliver sustainable solutions at scale. In Conclusion Environmental Horizons is not just a service provider; it is a partner in creating a more sustainable and environmentally responsible future for generations to come. Its award-winning approach reflects its unwavering commitment to excellence and its relentless pursuit of innovative solutions. As the company celebrates the recognition of being the Most Innovative Environmental Services Provider 2024 - Saudi Arabia, it remains focused on its mission to drive positive environmental change and contribute to the Kingdom’s sustainability goals. Through its comprehensive services, cutting-edge technologies, and deep industry expertise, it is shaping a greener, more sustainable future for Saudi Arabia and beyond. Environmental Horizons Co. Al Madina street, Fatimah Bint Rasul Allah, Jeddah 23531 Kingdom of Saudi Arabia Website: www.eh.net.sa Phone: 012 6053360; 012 6053505 Email: support @eh.net.sa LinkedIn: www.linkedin.com/company/eh-env Innovative Solutions for a Greener Future One of the hallmarks of EH is its ability to innovate. It continuously invests in the latest technologies and methodologies to enhance its service offerings. From advanced waste treatment technologies to cutting-edge environmental emergency response strategies, the company’s goal is to provide solutions that re both effective and forward-thinking. Its insulation and lining services for landfill cells are a prime example of its innovative approach. These services are essential in minimizing environmental impact and ensuring the long-term stability of waste containment systems. By employing state-of-the-art materials and techniques, it helps its clients manage waste more efficiently and responsibly. Its focus on innovation extends to all aspects of our operations, driving continuous improvement and ensuring that it remains at the forefront of the environmental services industry. A Track Record of Success With a client base exceeding 900 organizations, EH has built a reputation for reliability and excellence. Its extensive experience in handling complex projects across sectors such as oil and gas, power generation, mining, food and agriculture, downstream industries, desalination plants, and cement factories underscores its ability to deliver results that align with its clients’ environmental goals. It has played a pivotal role in numerous high-profile projects, demonstrating its capability to manage and resolve intricate environmental challenges. Its success is built on a foundation of strong partnerships, technical expertise, and a relentless commitment to achieving the highest standards of quality and performance. Looking Ahead As EH looks to the future, it is committed to advancing environmental stewardship and sustainability across the MENA region, with plans to
16 GHP Q3 2024 London-based Ink Illusions is a medical and cosmetic tattoo clinic on a mission to transform lives through instilling confidence in its clients by delivering high quality treatments. The clinic was founded in 2018 by Zena Bratcher, who has witnessed the miracle of medical tattooing firsthand. Below, we catch up with Zena to learn more, as Ink Illusions is named the Best Medical and Cosmetic Tattoo Clinic in the 2024 Global Excellence Awards. Zena founded Ink Illusions in 2018, driven by a passion for changing the lives of those around her. With extensive experience in the industry across multiple mediums, Zena was amazed at how medical tattooing can transform lives and bring back their confidence. The clinic specialises in medical tattooing for scalp micropigmentation, scars and stretch marks, areola tattooing following breast surgery, laser tattoo, PMU and pigmentation removal, and intense pulsed light for skin rejuvenation and hair removal. Ultimately, Ink Illusions aims to provide clients with a safe space in which they can address their body insecurities and leave feeling better about themselves. Ink Illusions is always looking to develop and improve upon existing protocols for its life-changing treatments, aiming to be at the cutting-edge of industry developments to ensure that clients are always receiving the highest possible standard of service. The clinic was the first in Europe to introduce techniques from the USA and Brazil for Stretch Mark Tattoo Camouflage and is the only clinic to teach a combination of those techniques alongside traditional methods in the UK. “These techniques have been hugely developed to make them both safer and more effective,” says Zena. “Our consistent level of results proves that what we are doing is different to any other clinic in the UK. We have also gone against the grain of those who have said that stretch marks should not be tattooed – an opinion that only comes from lack of skill and current knowledge.” Zena tells us that Ink Illusions’ most popular service is its Stretch Mark Revision, which is done through a combination of the MCA Inkless Needling and Skin Tone Tattoo Camouflage techniques. The use of MCA Inkless Needling aims to promote healing within the skin, to smooth, shrink, and flatten scars or stretchmarks while also bringing back natural pigmentation. Skin Tone Tattoo Camouflaging is the technique of tattooing over the skin using skin tone ink to camouflage scars or stretchmarks. “In cases where we have managed to improve the texture, but not enough melanin has been stimulated, we can then custom blend a skin tone colour to take away whiteness,” Zena explains. “Our clients get back their confidence and it is truly life changing in many cases.” This treatment is so popular that Ink Illusions has featured in a Metro article detailing one client’s success story, and the clinic boasts numerous reviews testifying to the efficacy, professionalism, and personability displayed during their treatments. “If you’re thinking about having this done, do it now,” writes one happy client. “What a fantastic experience and what a fantastic job! Zena is very professional, very detailed, and she wasn’t in any rush. After the first session, I couldn’t wait for the rest. I am so happy with what she has achieved. Don’t wait, get it done now.” “I am so happy and pleased with the service I’ve received from Ink Illusions,” says another. “Zena is so professional and has a great deal of knowledge about skin. She transformed and camouflaged my burn scar using the inkless needling method. I am so grateful and satisfied with the service that was provided to me. Communication was easy, access was easy, and the method worked out very well for me. I definitely recommend their services! Ink Illusions is providing an unbelievable service to the UK.” Going forward, Ink Illusions plans to continue its mission of enhancing the lives of individuals by helping them regain their confidence. Zena tells us that the clinic has new products in the works to be released this year. This will be in addition to its own serum, INKLESS, which is used with MCA inkless needling treatments. “We are currently developing some very exciting products which include our own ink colours for custom blending skin tones, as well as aftercare products,” Zena announces. “Our own pigment line will be released in 2024, which will have some unique properties that no other company has done yet. We are also in the process of becoming an OfQual regulated training centre.” If you are interested in the transformative treatments offered by Ink Illusions, you can visit the clinic’s website to learn more. Contact: Zena Bratcher Company: Ink Illusions Web Address: https://www.ink-illusion.com/ Restoring Confidence Through Transformative Tattoo Treatments Ink Illusioions Team, Left to right: Lucie, Zena & Sophie
ghpnews.digitalRkJQdWJsaXNoZXIy MTUyMDQwMA==